TD Cowen on Centessa Pharmaceuticals (CNTA): 'Stock Pullback Is A Good Entry Point'
Tweet Send to a Friend
TD Cowen analyst Stacy Ku reiterated a Buy rating on Centessa Pharmaceuticals (NASDAQ: CNTA).The analyst commented: "As We Await Higher ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
